GILI, ALESSIO

GILI, ALESSIO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 35 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autore(i) File
Accuracy and impact on patient management of new tools for diagnosis of sepsis: Experience with the t2 magnetic resonance bacteria panel 1-gen-2021 Paggi, R.; Cenci, E.; De Socio, G. V.; Belati, A.; Marini, D.; Gili, A.; Camilloni, B.; Mencacci, A.
Activating somatic and germline TERT promoter variants in myeloid malignancies 1-gen-2020 Nofrini, Valeria; Matteucci, Caterina; Pellanera, Fabrizia; Gorello, Paolo; DI GIACOMO, Danika; LEMA FERNANDEZ, ANAIR GRACIELA; Nardelli, Carlotta; Iannotti, Tamara; Brandimarte, Lucia; Arniani, Silvia; Moretti, Martina; Gili, Alessio; Roti, Giovanni; Di Battista, Valeria; Colla &, Simona; Mecucci, Cristina
Changes in Drug Use Patterns during the COVID-19 Pandemic in Italy: Monitoring a Vulnerable Group by Hair Analysis 1-gen-2021 Gili, Alessio; Bacci, Mauro; Aroni, Kyriaki; Nicoletti, Alessia; Gambelunghe, Angela; Mercurio, Isabella; Gambelunghe, Cristiana
Changing the smoking habit: Prevalence, knowledge and attitudes among Umbrian hospital healthcare professionals 1-gen-2017 Pianori, Davide; Gili, A.; Masanotti, Giuseppe Michele
Could thymomectomy be a reasonable option for non-myasthenic thymoma patients? 1-gen-2017 Tassi, Valentina; Ceccarelli, Silvia; Zannori, Cristina; Gili, Alessio; Bellezza, Guido; Ascani, Stefano; Liberati, Anna Marina; Puma, Francesco; Daddi, Niccolò
Cuff pressure monitoring by manual palpation in intubated patients: How accurate is it? A manikin simulation study 1-gen-2016 Giusti, GIAN DOMENICO; Rogari, Cecilia; Gili, Alessio; Nisi, Fulvio
Drug Checking as Strategy for Harm Reduction in Recreational Contests: Evaluation of Two Different Drug Analysis Methodologies 1-gen-2021 Fregonese, Martina; Albino, Andrea; Covino, Claudia; Gili, Alessio; Bacci, Mauro; Nicoletti, Alessia; Gambelunghe, Cristiana
Effects of an Intensive Lifestyle Intervention to Treat Overweight/Obese Children and Adolescents 1-gen-2017 Ranucci, Claudia; Pippi, Roberto; Buratta, Livia; Aiello, Cristina; Gianfredi, Vincenza; Piana, Natalia; Reginato, Elisa; Tirimagni, Alberto; Chiodini, Emanuele; SBROMA TOMARO, Emilia; Gili, Alessio; DE FEO, Pierpaolo; Fanelli, Carmine Giuseppe; Mazzeschi, Claudia
Effects of individual and social factors on preterm birth and low birth weigth: empirical evidence from regional data in Italy 1-gen-2012 Chiavarini, Manuela; Bartolucci, Francesco; Gili, Alessio; Pieroni, Luca; Minelli, Liliana
Efficacy of Pembrolizumab Monotherapy in Patients with or without Brain Metastases from Advanced Non-Small Cell Lung Cancer with a PD-L1 Expression ≥50% 1-gen-2020 Metro, G.; Banna, G. L.; Signorelli, D.; Gili, A.; Galetta, D.; Galli, G.; Economopoulou, P.; Roila, F.; Friedlaender, A.; Camerini, A.; Christopoulou, A.; Cantale, O.; De Toma, A.; Pizzutilo, P.; Jimenez, B.; Collazo-Lorduy, A.; Calles, A.; Baxevanos, P.; Linardou, H.; Kosmidis, P.; Giannarelli, D.; Mountzios, G.; Addeo, A.
Ethyl Glucuronide and Ethyl Sulphate in Urine: Caution in their use as markers of recent alcohol use 1-gen-2020 Mercurio, Isabella; Politi, Pamela; Mezzetti, Eleonora; Agostinelli, Fausto; Troiano, Gianmarco; Pellegrino, Adriana; Gili, Alessio; Melai, Paola; Rettagliata, George; Mercurio, Umberto; Sannicandro, Domenico; Lancia, Massimo; Bacci, Mauro
Evaluation of Lumipulse® G SARS-CoV-2 antigen assay automated test for detecting SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening 1-gen-2021 Gili, Alessio; Paggi, Riccardo; Russo, Carla; Cenci, Elio; Pietrella, Donatella; Graziani, Alessandro; Stracci, Fabrizio; Mencacci, Antonella
GC-MS/MS detects potential pregabalin abuse in susceptible subjects' hair 1-gen-2018 Ianni, Federica; Aroni, Kyriaki; Gili, Alessio; Sardella, Roccaldo; Bacci, Mauro; Lancia, Massimo; Natalini, Benedetto; Gambelunghe, Cristiana
Higher tlr7 gene expression predicts poor clinical outcome in advanced nsclc patients treated with immunotherapy 1-gen-2021 Baglivo, S.; Bianconi, F.; Metro, G.; Gili, A.; Tofanetti, F. R.; Bellezza, G.; Ricciuti, B.; Mandarano, M.; Teti, V.; Siggillino, A.; Reda, M. S.; Chiari, R.; Pistola, L.; Sidoni, A.; Minotti, V.; Roila, F.; Ludovini, V.
Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score ≥50% treated with front-line pembrolizumab 1-gen-2020 Friedlaender, A.; Metro, G.; Signorelli, D.; Gili, A.; Economopoulou, P.; Roila, F.; Banna, G.; De Toma, A.; Camerini, A.; Christopoulou, A.; Lo Russo, G.; Banini, M.; Galetta, D.; Jimenez, B.; Collazo-Lorduy, A.; Calles, A.; Baxevanos, P.; Linardou, H.; Kosmidis, P.; Mountzios, G.; Garassino, M. C.; Addeo, A.
Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool 1-gen-2020 Mandarano, M.; Bellezza, G.; Belladonna, M. L.; Vannucci, J.; Gili, A.; Ferri, I.; Lupi, C.; Ludovini, V.; Falabella, G.; Metro, G.; Mondanelli, G.; Chiari, R.; Cagini, L.; Stracci, F.; Roila, F.; Puma, F.; Volpi, C.; Sidoni, A.
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 1-gen-2019 Romoli, M.; Tuna, M. A.; Mcgurgan, I.; Li, L.; Giannandrea, D.; Eusebi, P.; Tordo Caprioli, F.; Lotti, A.; Salvadori, N.; Sarchielli, P.; Gili, A.; Mosconi, M. G.; Pellizzaro Venti, M.; Stracci, F.; Ricci, S.; Paciaroni, M.; Parnetti, L.; Calabresi, P.; Rothwell, P. M.
Monitoring people at risk of drinking by a rapid urinary ethyl glucuronide test 1-gen-2017 Fucci, Nadia; Gili, Alessio; Aroni, Kyriaki; Bacci, Mauro; Carletti, Paola; Pascali, Vincenzo Lorenzo; Gambelunghe, Cristiana
Norcocaine and cocaethylene distribution patterns in hair samples from light, moderate, and heavy cocaine users 1-gen-2017 Gambelunghe, Cristiana; Rossi, Riccardo; Aroni, Kyriaki; Gili, Alessio; Bacci, Mauro; Pascali, Vincenzo; Fucci, Nadia
Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 >= 50% who progress on first-line immunotherapy: real-world data from a European cohort 1-gen-2019 Metro, G.; Addeo, A.; Signorelli, D.; Gili, A.; Economopoulou, P.; Roila, F.; Banna, G.; De Toma, A.; Cobo, J. R.; Camerini, A.; Christopoulou, A.; Russo, G. L.; Banini, M.; Galetta, D.; Jimenez, B.; Collazo-Lorduy, A.; Calles, A.; Baxevanos, P.; Linardou, H.; Kosmidis, P.; Garassino, M. C.; Mountzios, G.